{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:30:28Z","timestamp":1789119028073,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021783","name":"Courtois Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021783","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DNA to RNA Scholarship, D2R"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biomed. Innov."],"DOI":"10.1038\/s44385-026-00111-8","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:33:11Z","timestamp":1789111991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating and comparing the signalling and functional landscape of hiPSC-CMs derived from patients with dilated cardiomyopathy"],"prefix":"10.1038","volume":"3","author":[{"given":"Giada","family":"Castagnola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Loggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Alim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Derish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Rody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zosia","family":"Gryz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Hawey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jace","family":"Jones-Tabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Mouttet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya K.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence E.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"111_CR1","unstructured":"Mahmaljy, H., Yelamanchili, V. S. & Singhal, M. Dilated Cardiomyopathy. in StatPearls (StatPearls Publishing, 2025)."},{"key":"111_CR2","doi-asserted-by":"crossref","unstructured":"Ferreira, A. et al. Dilated cardiomyopathy: a comprehensive approach to diagnosis and risk stratification. Biomedicines 11, 834 (2023).","DOI":"10.3390\/biomedicines11030834"},{"key":"111_CR3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","volume":"402","author":"S Heymans","year":"2023","unstructured":"Heymans, S. et al. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet 402, 998\u20131011 (2023).","journal-title":"Lancet"},{"key":"111_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41569-024-01074-2","volume":"22","author":"M Gigli","year":"2025","unstructured":"Gigli, M. et al. Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine. Nat. Rev. Cardiol. 22, 183\u2013198 (2025).","journal-title":"Nat. Rev. Cardiol."},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/cvr\/cvm084","volume":"77","author":"S Morimoto","year":"2007","unstructured":"Morimoto, S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc. Res. 77, 659\u2013666 (2007).","journal-title":"Cardiovasc. Res."},{"key":"111_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan, E. et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation 144, 7\u201319 (2021).","journal-title":"Circulation"},{"key":"111_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"H-P Schultheiss","year":"2019","unstructured":"Schultheiss, H.-P. et al. Dilated cardiomyopathy. Nat. Rev. Dis. Primers 5, 32 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub, R. G., Semsarian, C. & Macdonald, P. Dilated cardiomyopathy. Lancet 390, 400\u2013414 (2017).","journal-title":"Lancet"},{"key":"111_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/joim.12944","volume":"286","author":"D Reichart","year":"2019","unstructured":"Reichart, D. et al. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature. J. Intern Med. 286, 362\u2013372 (2019).","journal-title":"J. Intern Med."},{"key":"111_CR10","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","volume":"134","author":"RL Page","year":"2016","unstructured":"Page, R. L. et al. Drugs that may cause or exacerbate heart failure. Circulation 134, e32\u2013e69 (2016).","journal-title":"Circulation"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11886-020-1260-3","volume":"22","author":"P Marstrand","year":"2020","unstructured":"Marstrand, P., Picard, K. & Lakdawala, N. K. Second hits in dilated cardiomyopathy. Curr. Cardiol. Rep. 22, 8 (2020).","journal-title":"Curr. Cardiol. Rep."},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12471-012-0285-7","volume":"20","author":"M Hazebroek","year":"2012","unstructured":"Hazebroek, M., Dennert, R. & Heymans, S. Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies. Neth. Heart J. 20, 332\u2013335 (2012).","journal-title":"Neth. Heart J."},{"key":"111_CR13","doi-asserted-by":"crossref","unstructured":"Rahamim, E. et al. Contemporary pillars of heart failure with reduced ejection fraction medical therapy. J. Clin. Med. 10, 4409 (2021).","DOI":"10.3390\/jcm10194409"},{"key":"111_CR14","first-page":"531","volume":"37","author":"M McDonald","year":"2021","unstructured":"McDonald, M. et al. CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction. Can. J. Cardiol. 37, 531\u2013546 (2021).","journal-title":"Can. J. Cardiol."},{"key":"111_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/cvr\/cvac171","volume":"119","author":"A Grogan","year":"2023","unstructured":"Grogan, A. et al. Pathophysiology and pharmacology of G protein-coupled receptors in the heart. Cardiovasc. Res. 119, 1117\u20131129 (2023).","journal-title":"Cardiovasc. Res."},{"key":"111_CR16","doi-asserted-by":"publisher","first-page":"110239","DOI":"10.1016\/j.cellsig.2021.110239","volume":"91","author":"K Bourque","year":"2022","unstructured":"Bourque, K. et al. Biosensor-based profiling to track cellular signalling in patient-derived models of dilated cardiomyopathy. Cell. Signal. 91, 110239 (2022).","journal-title":"Cell. Signal."},{"key":"111_CR17","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","volume":"123","author":"J Wang","year":"2018","unstructured":"Wang, J., Gareri, C. & Rockman, H. A. G protein-coupled receptors in heart disease. Circ. Res. 123, 716\u2013735 (2018).","journal-title":"Circ. Res."},{"key":"111_CR18","doi-asserted-by":"publisher","first-page":"45417","DOI":"10.31083\/RCM45417","volume":"26","author":"A Cole","year":"2025","unstructured":"Cole, A. et al. Endothelin as a treatment target in cardiovascular diseases: a recent step forward. Rev. Cardiovasc. Med. 26, 45417 (2025).","journal-title":"Rev. Cardiovasc. Med."},{"key":"111_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41589-020-00660-y","volume":"17","author":"J-F Zhang","year":"2021","unstructured":"Zhang, J.-F. et al. An ultrasensitive biosensor for high-resolution kinase activity imaging in awake mice. Nat. Chem. Biol. 17, 39\u201346 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"111_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41556-018-0200-6","volume":"20","author":"S Mehta","year":"2018","unstructured":"Mehta, S. et al. Single-fluorophore biosensors for sensitive and multiplexed detection of signalling activities. Nat. Cell Biol. 20, 1215\u20131225 (2018).","journal-title":"Nat. Cell Biol."},{"key":"111_CR21","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1091\/mbc.e11-01-0072","volume":"22","author":"N Komatsu","year":"2011","unstructured":"Komatsu, N. et al. Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol. Biol. Cell 22, 4647\u20134656 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"111_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/biology10040346","volume":"10","author":"CJ Gilbert","year":"2021","unstructured":"Gilbert, C. J., Longenecker, J. Z. & Accornero, F. ERK1\/2: an integrator of signals that alters cardiac homeostasis and growth. Biology 10, 346 (2021).","journal-title":"Biology"},{"key":"111_CR23","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose, B. A., Force, T. & Wang, Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90, 1507\u20131546 (2010).","journal-title":"Physiol. Rev."},{"key":"111_CR24","doi-asserted-by":"publisher","first-page":"26281","DOI":"10.3390\/s151026281","volume":"15","author":"B Hochreiter","year":"2015","unstructured":"Hochreiter, B., Pardo-Garcia, A. & Schmid, J. A. Fluorescent proteins as genetically encoded FRET biosensors in life sciences. Sensors 15, 26281\u201326314 (2015).","journal-title":"Sensors"},{"key":"111_CR25","doi-asserted-by":"publisher","unstructured":"Sizaire, F. & Tramier, M. FRET-based biosensors: genetically encoded tools to track kinase activity in living cells. In \"Protein Phosphorylation\", published by InTechOpen, edited by Prigent, C. pp 179\u2013193 https:\/\/doi.org\/10.5772\/intechopen.71005 (2017).","DOI":"10.5772\/intechopen.71005"},{"key":"111_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1947601911407328","volume":"2","author":"I Wortzel","year":"2011","unstructured":"Wortzel, I. & Seger, R. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer 2, 195\u2013209 (2011).","journal-title":"Genes Cancer"},{"key":"111_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/CIRCRESAHA.123.322729","volume":"134","author":"Y Bai","year":"2024","unstructured":"Bai, Y. et al. Protein kinase A is a master regulator of physiological and pathological cardiac hypertrophy. Circ. Res. 134, 393\u2013410 (2024).","journal-title":"Circ. Res."},{"key":"111_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pbiomolbio.2020.02.008","volume":"157","author":"H Sutanto","year":"2020","unstructured":"Sutanto, H. et al. Cardiomyocyte calcium handling in health and disease: insights from in vitro and in silico studies. Prog. Biophys. Mol. Biol. 157, 54\u201375 (2020).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"111_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","volume":"21","author":"PA Gorski","year":"2015","unstructured":"Gorski, P. A., Ceholski, D. K. & Hajjar, R. J. Altered myocardial calcium cycling and energetics in heart failure-a rational approach for disease treatment. Cell Metab. 21, 183\u2013194 (2015).","journal-title":"Cell Metab."},{"key":"111_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/CIRCRESAHA.118.314600","volume":"124","author":"AJ Sparrow","year":"2019","unstructured":"Sparrow, A. J. et al. Measurement of myofilament-localized calcium dynamics in adult cardiomyocytes and the effect of hypertrophic cardiomyopathy mutations. Circ. Res. 124, 1228\u20131239 (2019).","journal-title":"Circ. Res."},{"key":"111_CR31","doi-asserted-by":"crossref","unstructured":"Hawey, C. et al. Measuring single-cell calcium dynamics using a myofilament-localized optical biosensor in hiPSC-CMs derived from DCM patients. Cells 12, 2526 (2023).","DOI":"10.3390\/cells12212526"},{"key":"111_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.vascn.2016.04.006","volume":"81","author":"A Obergrussberger","year":"2016","unstructured":"Obergrussberger, A. et al. Safety pharmacology studies using EFP and impedance. J. Pharmacol. Toxicol. Methods 81, 223\u2013232 (2016).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"111_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12012-014-9268-9","volume":"15","author":"MF Peters","year":"2015","unstructured":"Peters, M. F. et al. Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line. Cardiovasc. Toxicol. 15, 127\u2013139 (2015).","journal-title":"Cardiovasc. Toxicol."},{"key":"111_CR34","doi-asserted-by":"publisher","first-page":"107706","DOI":"10.1016\/j.vascn.2025.107706","volume":"133","author":"L Polonchuk","year":"2025","unstructured":"Polonchuk, L. Monitoring cardiomyocyte function with hybrid EFP-impedance technology for drug safety evaluation. J. Pharmacol. Toxicol. Methods 133, 107706 (2025).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"111_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"111_CR36","doi-asserted-by":"publisher","first-page":"101560","DOI":"10.1016\/j.xpro.2022.101560","volume":"3","author":"DM Lyra-Leite","year":"2022","unstructured":"Lyra-Leite, D. M. et al. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. STAR Protoc. 3, 101560 (2022).","journal-title":"STAR Protoc."},{"key":"111_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvv017","volume":"105","author":"T Eschenhagen","year":"2015","unstructured":"Eschenhagen, T., Mummery, C. & Knollmann, B. C. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc. Res. 105, 424\u2013438 (2015).","journal-title":"Cardiovasc. Res."},{"key":"111_CR38","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","volume":"114","author":"A van Mil","year":"2018","unstructured":"van Mil, A. et al. Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential. Cardiovasc. Res. 114, 1828\u20131842 (2018).","journal-title":"Cardiovasc. Res."},{"key":"111_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/HCO.0b013e32834598ad","volume":"26","author":"R Josowitz","year":"2011","unstructured":"Josowitz, R. et al. Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders. Curr. Opin. Cardiol. 26, 223\u2013229 (2011).","journal-title":"Curr. Opin. Cardiol."},{"key":"111_CR40","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1113\/JP276753","volume":"598","author":"LR Sewanan","year":"2020","unstructured":"Sewanan, L. R. & Campbell, S. G. Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells. J. Physiol. 598, 2909\u20132922 (2020).","journal-title":"J. Physiol."},{"key":"111_CR41","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/ijms20184381","volume":"20","author":"A Brodehl","year":"2019","unstructured":"Brodehl, A. et al. Human induced pluripotent stem-cell-derived cardiomyocytes as models for genetic cardiomyopathies. Int. J. Mol. Sci. 20, 4381 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"111_CR42","doi-asserted-by":"publisher","first-page":"10782","DOI":"10.1073\/pnas.1834556100","volume":"100","author":"H Wei","year":"2003","unstructured":"Wei, H. et al. Independent \u03b2-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. USA 100, 10782\u201310787 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"111_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0026-895X(24)12327-9","volume":"61","author":"AC Holloway","year":"2002","unstructured":"Holloway, A. C. et al. Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol. Pharm. 61, 768\u2013777 (2002).","journal-title":"Mol. Pharm."},{"key":"111_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39525-4","volume":"13","author":"K Bourque","year":"2023","unstructured":"Bourque, K. et al. Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes. Sci. Rep. 13, 12248 (2023).","journal-title":"Sci. Rep."},{"key":"111_CR45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1124\/molpharm.121.000290","volume":"100","author":"J Jones-Tabah","year":"2021","unstructured":"Jones-Tabah, J. et al. High-content single-cell f\u00f6rster resonance energy transfer imaging of cultured striatal neurons reveals novel cross-talk in the regulation of nuclear signaling by protein kinase A and extracellular signal-regulated kinase 1\/2. Mol. Pharmacol. 100, 526\u2013539 (2021).","journal-title":"Mol. Pharmacol."},{"key":"111_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/ten.tec.2017.0190","volume":"23","author":"KJ Hansen","year":"2017","unstructured":"Hansen, K. J. et al. Optical method to quantify mechanical contraction and calcium transients of human pluripotent stem cell-derived cardiomyocytes. Tissue Eng. Part C Methods 23, 445\u2013454 (2017).","journal-title":"Tissue Eng. Part C Methods"},{"key":"111_CR47","doi-asserted-by":"publisher","first-page":"H913","DOI":"10.1152\/ajpheart.00819.2012","volume":"305","author":"CY Ivashchenko","year":"2013","unstructured":"Ivashchenko, C. Y. et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am. J. Physiol. Heart Circ. Physiol. 305, H913\u2013H922 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"111_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","volume":"17","author":"H Wu","year":"2015","unstructured":"Wu, H. et al. Epigenetic regulation of phosphodiesterases 2A and 3A underlies compromised \u03b2-adrenergic signaling in an iPSC model of dilated cardiomyopathy. Cell Stem Cell 17, 89\u2013100 (2015).","journal-title":"Cell Stem Cell"},{"key":"111_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-5213-9","volume":"19","author":"ME Sweet","year":"2018","unstructured":"Sweet, M. E. et al. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genom. 19, 812 (2018).","journal-title":"BMC Genom."},{"key":"111_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41569-019-0284-0","volume":"17","author":"AN Rosenbaum","year":"2020","unstructured":"Rosenbaum, A. N., Agre, K. E. & Pereira, N. L. Genetics of dilated cardiomyopathy: practical implications for heart failure management. Nat. Rev. Cardiol. 17, 286\u2013297 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"111_CR51","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1161\/01.CIR.0000097493.70422.50","volume":"108","author":"L Ku","year":"2003","unstructured":"Ku, L. et al. Familial dilated cardiomyopathy. Circulation 108, e118\u2013e121 (2003).","journal-title":"Circulation"},{"key":"111_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger, R. E., Hedges, D. J. & Morales, A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 10, 531\u2013547 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"111_CR53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619\u2013628 (2012).","journal-title":"N. Engl. J. Med."},{"key":"111_CR54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacc.2009.05.009","volume":"54","author":"S Cresci","year":"2009","unstructured":"Cresci, S. et al. Clinical and genetic modifiers of long-term survival in heart failure. J. Am. Coll. Cardiol. 54, 432\u2013444 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"111_CR55","doi-asserted-by":"publisher","first-page":"H931","DOI":"10.1152\/ajpheart.2001.281.2.H931","volume":"281","author":"I Lemire","year":"2001","unstructured":"Lemire, I. et al. Cardiac-directed overexpression of wild-type \u03b11B-adrenergic receptor induces dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 281, H931\u2013H938 (2001).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"111_CR56","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1172\/JCI22811","volume":"116","author":"TD O\u2019Connell","year":"2006","unstructured":"O\u2019Connell, T. D. et al. \u03b11-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J. Clin. Investig. 116, 1005\u20131015 (2006).","journal-title":"J. Clin. Investig."},{"key":"111_CR57","doi-asserted-by":"crossref","unstructured":"Martin, R. D. et al. Differential activation of P-TEFb complexes in the development of cardiomyocyte hypertrophy following activation of distinct G protein-coupled receptors. Mol. Cell Biol. 40, e00048-20 (2020).","DOI":"10.1128\/MCB.00048-20"},{"key":"111_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cellsig.2018.01.002","volume":"44","author":"RD Martin","year":"2018","unstructured":"Martin, R. D. et al. Receptor- and cellular compartment-specific activation of the cAMP\/PKA pathway by \u03b11-adrenergic and ETA endothelin receptors. Cell Signal. 44, 43\u201350 (2018).","journal-title":"Cell Signal."},{"key":"111_CR59","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bbrc.2006.07.136","volume":"348","author":"MD Allen","year":"2006","unstructured":"Allen, M. D. & Zhang, J. Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem. Biophys. Res. Commun. 348, 716\u2013721 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"111_CR60","doi-asserted-by":"publisher","unstructured":"Zhang, J.-F. et al. Sensitive and selective next-generation FRET-based PKA biosensors. Preprint at bioRxiv, https:\/\/doi.org\/10.64898\/2026.02.06.702976 (2026).","DOI":"10.64898\/2026.02.06.702976"},{"key":"111_CR61","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3389\/fphys.2019.01038","volume":"10","author":"T Kong","year":"2019","unstructured":"Kong, T. et al. Role of the extracellular signal-regulated kinase 1\/2 signaling pathway in ischemia-reperfusion injury. Front. Physiol. 10, 1038 (2019).","journal-title":"Front. Physiol."},{"key":"111_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2024.07.004","volume":"194","author":"C Redwanz","year":"2024","unstructured":"Redwanz, C. et al. Endothelin-1 influences mechanical properties and contractility of hiPSC derived cardiomyocytes resulting in diastolic dysfunction. J. Mol. Cell. Cardiol. 194, 105\u2013117 (2024).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"111_CR63","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1097\/00004872-198900076-00044","volume":"7","author":"V Concas","year":"1989","unstructured":"Concas, V. et al. Endothelin has potent direct inotropic and chronotropic effects in cultured heart cells. J. Hypertens. Suppl. 7, S96\u2013S97 (1989).","journal-title":"J. Hypertens. Suppl."},{"key":"111_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.scr.2010.09.001","volume":"6","author":"EL Lagerqvist","year":"2011","unstructured":"Lagerqvist, E. L. et al. Endothelin-1 and angiotensin II modulate rate and contraction amplitude in a subpopulation of mouse embryonic stem cell-derived cardiomyocyte-containing bodies. Stem Cell Res. 6, 23\u201333 (2011).","journal-title":"Stem Cell Res."},{"key":"111_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.hrthm.2006.12.047","volume":"4","author":"VV Fedorov","year":"2007","unstructured":"Fedorov, V. V. et al. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 4, 619\u2013626 (2007).","journal-title":"Heart Rhythm"},{"key":"111_CR66","doi-asserted-by":"publisher","first-page":"E7486","DOI":"10.1073\/pnas.1720342115","volume":"115","author":"JA Rohde","year":"2018","unstructured":"Rohde, J. A. et al. Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin. Proc. Natl. Acad. Sci. USA 115, E7486\u2013E7494 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"111_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nprot.2012.150","volume":"8","author":"X Lian","year":"2013","unstructured":"Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162\u2013175 (2013).","journal-title":"Nat. Protoc."},{"key":"111_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v062.i01","volume":"62","author":"P Montero","year":"2014","unstructured":"Montero, P. & Vilar, J. A. TSclust: an R package for time series clustering. J. Stat. Softw. 62, 1\u201343 (2014).","journal-title":"J. Stat. Softw."}],"container-title":["npj Biomedical Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44385-026-00111-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44385-026-00111-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44385-026-00111-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:04:12Z","timestamp":1789117452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44385-026-00111-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1038\/s44385-026-00111-8","relation":{},"ISSN":["3005-1444"],"issn-type":[{"value":"3005-1444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"55"}}